CaMKII as a Therapeutic Target in Cardiovascular Disease

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiovascular Research

Background:

• Calcium/calmodulin-dependent protein kinase II (CaMKII) is a critical signaling molecule implicated in numerous diseases, especially cardiovascular conditions.
• Despite extensive preclinical evidence, CaMKII inhibitors have not yet translated into clinical practice.
• Challenges include CaMKII's diverse isoforms/splice variants and its essential role in physiological processes like learning and memory.

Purpose of the Study:

• To review the cellular and molecular biology of CaMKII.
• To discuss CaMKII's role in both physiological and pathological signaling pathways.
• To explore emerging therapeutic strategies for selectively targeting pathological CaMKII activity.

Main Methods:

• Review of existing literature on CaMKII.
• Analysis of CaMKII's function in various disease models.
• Evaluation of novel therapeutic approaches, including small molecules, peptides, and nucleotides.

Main Results:

• CaMKII plays a dual role, contributing to both disease pathogenesis and essential physiological functions.
• Developing effective CaMKII inhibitors requires discriminating between harmful and beneficial activities.
• Recent advancements in targeting strategies show promise for selective inhibition.

Conclusions:

• Selective inhibition of pathological CaMKII activity is crucial for therapeutic success.
• Emerging targeting strategies offer potential for developing CaMKII-based therapies.
• Further research is needed to translate these findings into clinical applications for treating diseases.